Drug Type Small molecule drug |
Synonyms BNT 24005, BNT24005 |
Target |
Action inhibitors |
Mechanism mTOR inhibitors(Serine/threonine-protein kinase mTOR inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Graft Rejection | Preclinical | Canada | 01 Nov 2025 |





